Very early versus early disease: The evolving definition of the 'many faces' of systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 72, Issue 3, 2013, Pages 319-321

  Matucci Cerinic, Marco ^a   Bellando Randone, Silvia ^a   Lepri, Gemma ^a   Bruni, Cosimo ^a   Guiducci, Serena ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

COMORBIDITY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; NOTE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SKIN FIBROSIS; SYSTEMIC SCLEROSIS;

EARLY DIAGNOSIS; HUMANS; SCLERODERMA, SYSTEMIC;

EID: 84873619082     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202295     Document Type: Note

References (15)

1. Lonzetti LS, Joyal F, Raynauld JP, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
2. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202.
3. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
4. Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007;66:754-63.
5. Hudson M, Taillefer S, Steele R, et al. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007;25:754-7.
6. Czirjak L, Matucci-Cerinic M. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory. Rheumatology 2011;50:250-1.
7. Matucci-Cerinic M, Allanore Y, Czirják L, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009;68:1377-80.
8. Avouac J, Fransen J, Walker UA, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis (VEDOSS): results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group (EUSTAR). Ann Rheum Dis 2010;69 (Suppl 3):128.
9. Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-12.
10. LeRoy EC. Sentinel signs and symptoms of systemic sclerosis. Curr Opin Rheumatol 1990;2:942.
11. Lepri G, Giani G, Bellando Randone S, et al. Esophageal and anorectal involvement in patients with very early diagnosis of systemic sclerosis (VEDOSS): report from a single EUSTAR centre. (Submitted).
12. Valentini G, Cuomo G, Abignano G, et al. Early systemic sclerosis: assessment of clinical and preclinical organ involvement in patients with different disease features. Rheumatology 2011;50:317-23.
13. Valentini G, Vettori S, Cuomo G, et al. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther 2012;17:R188.
14. Johnson SR, Fransen J, Khanna D, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64: 358-67.
15. Kowal-Bielecka O, Landewé R, Avouac J, et al. EULAR/EUSTAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2009;68:620-8.